Filter
942
Filtered Results: 942
Text search:
medicine
manufacturing
Featured
Recommendations
79
New Publications
216
Language
Document type
No document type
403
Studies & Reports
216
Guidelines
156
Strategic & Response Plan
60
Manuals
57
Fact sheets
25
Situation Updates
10
Training Material
7
Resource Platforms
4
Brochures
2
Infographics
1
Videos
1
Countries / Regions
Global
44
India
41
Kenya
36
Nigeria
25
Uganda
23
Ghana
21
Ethiopia
21
Africa
18
Tanzania
16
Western and Central Europe
16
South Africa
16
Nepal
13
Zambia
13
Sierra Leone
12
Rwanda
12
Bangladesh
12
Lesotho
10
Philippines
10
South–East Asia Region
9
Namibia
9
Malawi
8
West and Central Africa
8
East and Southern Africa
8
Liberia
8
Myanmar / Burma
8
Ukraine
7
Syria
7
Zimbabwe
7
Latin America and the Carribbean
7
Botswana
7
Eastern Europe
5
Indonesia
5
Thailand
4
USA
4
Haiti
4
Cambodia
4
Congo, Democratic Republic of
4
Eswatini/ Swaziland
4
Cameroon
3
Albania
3
Asia
3
Moldova
3
Sri Lanka
3
Russia
3
South Sudan
3
Pakistan
3
Tajikistan
2
Benin
2
China
2
Laos
2
Senegal
2
Guinea
2
Mozambique
2
Middle East and North Africa
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Mauritius
2
United Kingdom
2
Sudan
2
Yemen
2
Serbia
1
Australia
1
Afghanistan
1
Mongolia
1
Jordan
1
Germany
1
Turkmenistan
1
Maldives
1
Bosnia and Herzegovina
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Vietnam
1
Brazil
1
Egypt
1
Angola
1
Chad
1
Iraq
1
Ecuador
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
352
Clinical Guidelines
70
Public Health
41
Pharmacy & Technologies
37
Key Resources
31
Women & Child Health
16
Capacity Building
8
Toolboxes
COVID-19
106
Pharmacy
92
AMR
91
HIV
58
Planetary Health
49
TB
38
Mental Health
30
NTDs
25
Malaria
23
NCDs
17
Global Health Education
17
Rapid Response
15
Health Financing Toolbox
15
Ebola & Marburg
14
Disability
13
Conflict
13
Specific Hazards
10
Caregiver
8
2.0 Rapid Response
8
Natural Hazards
7
Refugee
4
Cholera
3
Zika
1
Polio
1
Rwanda Guidelines for variation to registered pharmaceutical products.
Working Document Nov. 2020
The COVAX Supply and Logistics workstream lead by UNICEF, Gavi and WHO have released a working copy of the COVID-19 Vaccination, Country Readiness & Delivery: Supply and Logistics Guidance. Countries might find this Guide useful when developing and strengthening their sup...
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0
PQDx 0033-013-00 WHO
PQ Public Report
July/2016, version 5.0
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
The Ghana National Malaria Strategic Plan 2021–2025 aims to reduce malaria mortality by 90% and malaria cases by 50% (using 2019 as baseline) and to achieve pre-elimination in at least six districts by 2025. The plan focuses on scaling up prevention measures like distributing insecticide-treated n...
This plan, approved by the Organization’s 62nd Directing Council, was shaped by extensive consultations with countries and stakeholders, and commits to transformative health outcomes over the next six years, tackling noncommunicable diseases (NCDs), mental health, health security, fragmented healt...
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul...
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This...
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...
